ACUTE MYELOGENOUS LEUKEMIA (AML)
Clinical trials for ACUTE MYELOGENOUS LEUKEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOGENOUS LEUKEMIA (AML) trials appear
Sign up with your email to follow new studies for ACUTE MYELOGENOUS LEUKEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood disorder: gentler transplant trial seeks to save lives
Disease control Recruiting nowThis study is testing a modified stem cell transplant procedure for patients with Fanconi anemia who have developed severe blood problems like bone marrow failure or leukemia. The goal is to see if using lower doses of certain chemotherapy drugs and removing another medication ca…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA (AML)
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Early trial aims to tame tough cancers with Two-Pronged attack
Disease control Recruiting nowThis early-stage study is testing the safety and best dose of a two-drug combination (alpelisib and pembrolizumab) for patients with advanced breast cancer or melanoma that has spread. It aims to see if this combo can help control the disease, including in cases where cancer has …
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA (AML)
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug combo targets tough blood cancers
Disease control Recruiting nowThis study is testing a new drug, NADUNOLIMAB, in combination with standard treatments for two types of blood cancer: Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). The main goals are to find a safe dose and see if this new combination can help control the disea…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA (AML)
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New hope for tough blood cancers: optimized transplant trial seeks to control disease
Disease control Recruiting nowThis study is collecting information on patient outcomes after receiving a cord blood transplant using Memorial Sloan Kettering's optimized procedure. It aims to see how well this standard transplant approach works for adults with high-risk blood cancers like leukemia, lymphoma, …
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA (AML)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC